EUVIMEDEUVIMED entdecken
Crossref

Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping

Satoshi Kambayashi iD, Nanae Ono, Tomofumi Tone, Kenji Baba iD, Masaru Okuda

Veterinary and Comparative Oncology · 2024-06 · 22 (2) · 303-309

DOI: 10.1111/vco.12961 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, online erschienen am 29.01.2024. Verfasst von Satoshi Kambayashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Internal Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan. Hauptthemen laut MEDLINE: Dog Diseases, Lymphoma, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Canine lymphoma is a disease with high morbidity and poor long‐term prognosis, despite a high response rate to chemotherapy. In this study, we focused on liquid biopsy, in which small amounts of substances from body fluids were analysed, to determine whether cell‐free DNA (cfDNA) in the plasma can be used as a biomarker for lymphoma in dogs. We found that 23 patients with lymphoma had significantly higher cfDNA concentrations than the 12 healthy dogs (median 2360 ng/mL versus 299 ng/mL, p < .0001). Polymerase chain reaction for antigen receptor rearrangement (PARR) was also employed using cfDNA from the lymphoma group to investigate whether cfDNA could be used for the detection of genetic clonality of lymphomas, as well as the genomic DNA (gDNA) extracted from an original lesion in each case. The correlation of the PARR results between cfDNA and gDNA was observed in 100% of B‐cell lymphomas (10/10), 77.8% of T‐cell lymphomas (7/9), and 100% of other types of lymphomas (4/4), respectively. These results indicate that plasma cfDNA levels are increasing in canine lymphoma patients, that cfDNA concentration can be a novel diagnostic tool, and that it can be used as a diagnostic tool for PARR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesLymphomaCell-Free Nucleic AcidsDogsAnimalsFemaleMaleBiomarkers, TumorGenotypePolymerase Chain ReactionDNA, Neoplasm

Stichwörter der Autor:innen

PARRbiomarkerscfDNAliquid biopsylymphoma

Substanzen

Cell-Free Nucleic AcidsBiomarkers, TumorDNA, Neoplasm

Autor:innen und Institutionen

  • Department of Veterinary Internal Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.
  • Laboratory of Veterinary Internal Medicine, Joint Graduate School of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.

ORCID-Profile: Satoshi Kambayashi, Kenji Baba

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kambayashi, S., Ono, N., Tone, T., Baba, K., & Okuda, M. (2024). Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping. Veterinary and Comparative Oncology, 22(2), 303-309. https://doi.org/10.1111/vco.12961

Vancouver

Kambayashi S, Ono N, Tone T, Baba K, Okuda M. Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping. Veterinary and Comparative Oncology. 2024;22(2):303-309. doi:10.1111/vco.12961

BibTeX
@article{Kambayashi2024,
  author = {Kambayashi, Satoshi and Ono, Nanae and Tone, Tomofumi and Baba, Kenji and Okuda, Masaru},
  title = {Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping},
  journal = {Veterinary and Comparative Oncology},
  year = {2024},
  volume = {22},
  number = {2},
  pages = {303--309},
  doi = {10.1111/vco.12961}
}
Kostenlos starten →